Stock 6622 ZHAOKE OPHTHALMOLOGY LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Zhaoke Ophthalmology Limited

Equities

6622

KYG989M51017

Pharmaceuticals

Market Closed - Hong Kong S.E.
Other stock markets
 01:38:22 10/05/2024 pm IST 		5-day change 1st Jan Change
1.56 HKD +2.63% Intraday chart for Zhaoke Ophthalmology Limited -0.64% -60.51%
29/04 Zhaoke Ophthalmology Shrinks Loss in 2023 MT
08/04 Zhaoke Ophthalmology Limited Announces the Resignation of Chen Yu Has as Non-Executive Director CI

Valuation

Fiscal Period: December 2021 2022 2023 2024 2025
Capitalization 1 2,517 1,451 787.8 787.8 -
Enterprise Value (EV) 1 417.5 -237.3 1,961 -272.7 103.7
P/E ratio -0.9 x -3.56 x -5.06 x - -
Yield - - - - -
Capitalization / Revenue - - 105 x 27 x 5.24 x
EV / Revenue - - 105 x -9.36 x 0.69 x
EV / EBITDA -1.23 x 0.64 x -4.82 x 0.66 x -0.27 x
EV / FCF - - - - -
FCF Yield - - - - -
Price to Book 1.01 x 0.62 x - - -
Nbr of stocks (in thousands) 5,41,947 5,43,844 5,46,139 5,46,139 -
Reference price 2 4.644 2.667 1.443 1.443 1.443
Announcement Date 23/03/22 27/03/23 27/03/24 - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2020 2021 2022 2023 2024 2025
Net sales 1 - - - 18.75 29.14 150.4
EBITDA 1 - -338.5 -369.1 -406.4 -413.9 -377.7
EBIT 1 - -364.3 -404.2 -455.1 -442.9 -404.4
Operating Margin - - - -2,427.18% -1,519.72% -268.91%
Earnings before Tax (EBT) - - -407.3 - - -
Net income -727 -2,130 -407.3 - - -
Net margin - - - - - -
EPS - -5.160 -0.7500 -0.7100 - -
Free Cash Flow - - - - - -
FCF margin - - - - - -
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 16/04/21 23/03/22 27/03/23 27/03/24 - -
1CNY in Million
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 S1 2021 S2 2022 S1 2022 S2 2023 S1 2023 S2 2024 S1 2024 S2
Net sales 1 - - - - 11.3 7.446 11.66 17.48
EBITDA - - - - - - - -
EBIT 1 -122.4 -241.9 -137.6 -266.6 -214.5 -240.6 -207.8 -235
Operating Margin - - - - -1,897.92% -3,230.66% -1,782.91% -1,344.27%
Earnings before Tax (EBT) - - - - - - - -
Net income - - - - - - - -
Net margin - - - - - - - -
EPS - - - - - - - -
Dividend per Share - - - - - - - -
Announcement Date 18/08/21 23/03/22 24/08/22 27/03/23 23/08/23 27/03/24 - -
1CNY in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2020 2021 2022 2023 2024 2025
Net Debt 1 - - - - - -
Net Cash position 1 - 2,100 1,688 1,201 1,061 684
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow - - - - - -
ROE (net income / shareholders' equity) - -243% -16.8% - - -
ROA (Net income/ Total Assets) - - -15.7% - - -
Assets - - 2,588 - - -
Book Value Per Share - 4.600 4.320 - - -
Cash Flow per Share - -0.5900 -0.6100 - - -
Capex - 50.4 54.9 - - -
Capex / Sales - - - - - -
Announcement Date 16/04/21 23/03/22 27/03/23 27/03/24 - -
1CNY in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
1.443 CNY
Average target price
7.1 CNY
Spread / Average Target
+392.23%
Consensus

Quarterly revenue - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
ZHAOKE OPHTHALMOLOGY LIMITED Stock Zhaoke Ophthalmology Limited
-60.51% 109M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+30.38% 684B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+26.51% 568B
JOHNSON & JOHNSON Stock Johnson & Johnson
-4.36% 361B
MERCK & CO., INC. Stock Merck & Co., Inc.
+19.30% 329B
ABBVIE INC. Stock AbbVie Inc.
+3.73% 284B
ASTRAZENECA PLC Stock AstraZeneca PLC
+16.70% 240B
NOVARTIS AG Stock Novartis AG
+8.78% 208B
ROCHE HOLDING AG Stock Roche Holding AG
-7.93% 200B
AMGEN INC. Stock Amgen Inc.
+7.68% 166B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 6622 Stock
  4. Financials Zhaoke Ophthalmology Limited
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW